Malaria and tuberculosis co-infection-a review
Else M Bijker1,2, Sanjay Deshpande3, Padmini Salgame
1Department of Paediatrics, Oxford Vaccine Group, University of Oxford, Oxford, OX3 7LE, UK.
Oxford Open Immunology
|December 13, 2023
Summary
Malaria and tuberculosis co-infection is understudied, yet animal data suggest malaria impairs the body's ability to fight tuberculosis. Further research is crucial to understand these immune interactions.
Area of Science:
- Infectious Diseases
- Immunology
- Global Health
Background:
- Malaria and tuberculosis are prevalent global infectious diseases with overlapping endemic regions.
- Co-infections are common, but malaria-tuberculosis co-infection is surprisingly understudied.
- Malaria is known to modulate immune responses, potentially affecting co-infections.
Purpose of the Study:
- To highlight the understudied nature of malaria-tuberculosis co-infection.
- To review existing evidence, primarily from animal studies, on the impact of co-infection on immune responses.
- To identify knowledge gaps and suggest future research directions.
Main Methods:
- Review of existing literature, with a focus on animal studies investigating malaria-tuberculosis co-infection.
- Analysis of immunological mechanisms suggested by experimental data.
- Consideration of human observations, though limited.
Main Results:
- Animal studies consistently demonstrate reduced control of mycobacteria during malaria infection.
- Evidence suggests malaria may skew immune responses against tuberculosis.
- Underlying immunological mechanisms, such as altered pro- and anti-inflammatory balance, are not fully understood.
Conclusions:
- Malaria-tuberculosis co-infection has significant, yet underappreciated, implications for disease pathophysiology and clinical outcomes.
- Further research is essential to elucidate the immunological mechanisms involved.
- Understanding these interactions is critical for potential clinical practice implications.
Related Concept Videos
Pulmonary Tuberculosis I
244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
Pulmonary Tuberculosis II
240
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
240
Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Pulmonary Tuberculosis III
334
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
334
Pulmonary Tuberculosis IV
143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143


